Tuberculosis

|2 min read

New Portable TB Test Matches Lab Accuracy in Minutes

MiniDock MTB, a battery-powered molecular TB test, delivers accurate results in under 30 minutes without lab equipment, expanding access in low-resource settings
Updated |1 min read

A Simple Blood Test Could Detect TB in Asymptomatic Patients

Tuberculosis is the world's deadliest infectious disease and kills more than 1 million people each year, per the WHO
|2 min read

Mycobacteria Present in Symptomatic Patients with Suspected TB

Study shows that Mtb is present in the exhaled breath of 90 percent of people suspected to have TB, despite their negative sputum tests
|3 min read

Tuberculous Meningitis Drug Regimen Trial Begins

The six-month multidrug regimen will be evaluated against standard treatment
|4 min read

BCG Challenge Unlocks Insights into TB Vaccine Research

Scientists believe they can use one vaccine to study the modus operandi and efficacy of others
|3 min read

Trials Reveal First-Ever MDR-TB Treatment Safe for Kids and Adults

Bayesian analysis of data from both trials showed that levofloxacin reduced the risk of developing TB by 60 percent
|2 min read

New Blood-Based Tool Rapidly Tests for TB in Children

 An international research consortium has tested a rapid new analytical tool that needs just a blood sample from a fingerprick

|1 min read

WHO Launches Comprehensive Web-Based TB Screening Tool

ScreenTB is free for all to use and could help countries track and monitor TB’s spread

|3 min read

Can Phage-Based Diagnostics End the Global TB Rage?

Natural mechanisms of bacteriophages may help identify active TB early in those at risk
|3 min read

New Guideline to Promote Health Equity in Canada

16 recommendations to help people facing disadvantages and barriers to accessing health care
|3 min read

Clovibactin: Bacterium-Derived New Antibiotic on the Block

Novel antibiotic disrupts peptidoglycan layer's structural integrity, forces autolysin release in Gram-positive bacteria
|2 min read

WHO Issues Guidance on Targeted NGS for Drug-Resistant TB Diagnosis

Rapid communication to update stakeholders on the changes in the drug-resistant TB detection options
|2 min read

NIH Study: Three-Month TB Regimen in Trial Safe but Ineffective

Identifying shorter TB treatment regimens may reduce demands on health systems worldwide
Page 1 of 4